Category: Healthcare
-
Liver Fibrosis Treatment Market
—
by
The global liver fibrosis treatment market is set to reach an impressive valuation of USD 17.43 billion in 2025 and is projected to grow at a CAGR of 12%
-
Liver Transplantation Market
—
by
The Global Liver Transplantation Market is set for substantial growth, reaching USD 2,409.8 million in 2025 and is projected to expand at a CAGR of 7.5%,
-
Livestock Vaccine Market
—
by
The global livestock vaccine market is projected to reach USD 7.1 billion in 2025 and expand significantly, attaining a market value of USD 12.2 billion by 2035, at a CAGR of 7.2%
-
Localized Temperature Therapy Products Market
—
by
The Global Localized Temperature Therapy Products Market is poised for substantial growth, reaching USD 2,752.9 million in 2025 and is projected to expand at a CAGR of 6.7%
-
Long-Acting Monoclonal Antibodies Market
—
by
The global long-acting monoclonal antibodies (mAbs) market is forecasted to reach USD 7.5 billion in 2025, expanding significantly to USD 15.5 billion by 2035, with a CAGR of 9.4%
-
Long-Term Post-Acute Care Software Market
—
by
The Global Long-Term Post-Acute Care (LTPAC) Software Market is poised for substantial growth, reaching USD 4,895.56 million in 2025 and is projected to expand at a CAGR of 12.3%
-
Loop-Mediated Isothermal Amplification Market
—
by
The Global Loop-Mediated Isothermal Amplification (LAMP) Market is set for steady expansion, reaching USD 111.6 million in 2025 and projected to grow at a CAGR of 5.9%,
-
Opioid Substitution Therapy Market
—
by
The global opioid substitution therapy market in low and middle-income countries is projected to reach USD 806.2 million by 2024, growing at a compound annual growth rate (CAGR) of 8.4%
-
Low-Frequency Ultrasound Market
—
by
The global low-frequency ultrasound market is experiencing rapid expansion, driven by advancements in non-invasive therapeutic solutions, ultrasound technology innovation, and increasing preventive healthcare awareness. The market, valued at USD 1,240.1 million in 2025, is projected to reach USD 2,066.1 million by 2035, growing at a CAGR of 6.2%.
-
Low-Grade Glioma Therapeutics Market
—
by
The global low-grade glioma therapeutics market is projected to reach USD 1,039 million in 2025, growing significantly to USD 1,516 million by 2035, at a CAGR of 5.57%
